Nucleotide stimulation of G q -coupled P2Y receptors expressed in Xenopus laevis oocytes produces the activation of an endogenous voltage-gated ion channel, previously identified as the transient inward (T in ) channel. Expression of human P2Y 1 , human P2Y 2 , rat P2Y 6 , human P2Y 11 , or skate P2Y receptors in oocytes resulted in modulation of the voltage dependence and inactivation gating of the channel. Expression of the human P2Y 4 receptor, rat M 1 -muscarinic receptor, and human B 1 -bradykinin receptor did not alter the properties of the T in channel. Replacement of the C-terminal domain of the human B 1 -bradykinin receptor with the C-terminal domains of either the human P2Y 1 or human P2Y 2 receptor resulted in voltage dependence and inactivation-gating properties, respectively, of the T in channel that were similar to those elicited by the respective native P2Y receptor. Systematic truncation of the C-terminal region of the human P2Y 1 receptor identified a short region responsible for modulation of the T in channel. This region contains a conserved sequence motif found in all P2Y receptors that modulates the voltage dependence of the T in channel. Synthetic 20-mer peptides from the C-terminal domains of human P2Y 1 and P2Y 2 receptors produced a shift in the voltage dependence and slowed inactivation gating, respectively, after injection into oocytes expressing human B 1 -bradykinin or truncated human P2Y 1 receptors. These results indicate that certain P2Y receptors are capable of modulating the voltage sensitivity and inactivation gating of an endogenous oocyte ion channel through interactions involving the C-terminal region of the receptor. Such modulation of ion channel function could also exist in native mammalian cells that express P2Y receptors.
nal region of the human P2Y 1 receptor identified a short region responsible for modulation of the T in channel. This region contains a conserved sequence motif found in all P2Y receptors that modulates the voltage dependence of the T in channel. Synthetic 20-mer peptides from the C-terminal domains of human P2Y 1 and P2Y 2 receptors produced a shift in the voltage dependence and slowed inactivation gating, respectively, after injection into oocytes expressing human B 1 -bradykinin or truncated human P2Y 1 receptors. These results indicate that certain P2Y receptors are capable of modulating the voltage sensitivity and inactivation gating of an endogenous oocyte ion channel through interactions involving the C-terminal region of the receptor. Such modulation of ion channel function could also exist in native mammalian cells that express P2Y receptors.
Extracellular nucleotides (ADP, ATP, UDP, and UTP) function as signaling molecules that mediate a variety of biological effects through a family of cell surface receptors known as P2 receptors. This family is divided into two groups: the ionotropic P2X receptors and the metabotropic P2Y receptors (Dubyak and el-Moatassim, 1993; Boarder et al., 1995; Boarder and Hourani, 1998; Ralevic and Burnstock, 1998) . Currently, seven mammalian P2X receptors (P2X 1-7 ) and eight mammalian P2Y receptors (P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 , and P2Y 14 ) have been cloned and functionally characterized (Ralevic and Burnstock, 1998; von Kugelgen and Wetter, 2000; Communi et al., 2001; Nicholas, 2001; Sak and Webb, 2002) . P2X receptors function as nonselective cation channels with inwardly rectifying currentvoltage relationships (Dubyak and el-Moatassim, 1993; Ralevic and Burnstock, 1998) . Activation of these receptors with ATP or 2-methylthio-ATP (2MeS-ATP) produces membrane depolarization. P2Y 1 , P2Y 2 , P2Y 4 , and P2Y 6 receptors couple to G q/11 and activate phospholipase C, resulting in increased inositol phosphate-3 formation and mobilization of intracellular Ca 2ϩ (Parr et al., 1994; Communi et al., 1995; Schachter et al., 1996; Lazarowski et al., 2001) . The P2Y 11 receptor activates both phospholipase C and adenylyl cyclase , whereas P2Y 12 and P2Y 13 receptors are coupled solely to G i and inhibition of adenylyl cyclase (Daniel et al., 1998; Hollopeter et al., 2001) . P2Y 14 receptors are orphan G protein-coupled receptors that are activated by UDP-glucose and couple to the G i/o class of G proteins (Chambers et al., 2000) . The skate (s) P2Y receptor has 61 to 64% sequence similarity to the human (h) P2Y 1 receptor, is coupled to G q /phospholipase C, and has a rank order of potency similar to the P2Y 1 receptor (Dranoff et al., 2000) .
Previously, we showed that agonist activation of the P2Y 1 receptor expressed in Xenopus laevis oocytes stimulated a slowly activating inward current that inactivated within seconds after stimulation (O'Grady et al., 1996) . The channel exhibits steady-state inactivation at strong hyperpolarizing potentials. This inward current was identified previously as the transient inward (T in ) current and was first observed after injection of mRNA from rat brain (Parker et al., 1985) and subsequently observed when cloned 5-hydroxytryptamine-1a and 5-hydroxytryptamine-2c receptors were expressed in oocytes (Ni et al., 1997) . The channel is expressed in stage V and VI oocytes but seems to be absent in earlier stages of oocyte maturation. It is reversibly blocked by polyvalent cations including Ba 2ϩ , Mn 2ϩ , and La 3ϩ . T in current activation requires membrane hyperpolarization and an increase in intracellular Ca 2ϩ (Parker et al., 1985; Ni et al., 1997) . Expression of G␣ q in mature oocytes was found to be sufficient for activation of the T in current (Guttridge et al., 1995) . The channel responsible for the T in current has not been cloned and seems to represent a new family of ion channels that has not been previously characterized.
Interactions between expressed membrane proteins and endogenous ion channels that produce altered properties of these channels have been documented previously. For example, previous studies of Ca 2ϩ -activated Cl Ϫ channels (CaCC) in bovine artery endothelial cells showed that biophysical properties of the channel could be modulated by expression of cystic fibrosis transmembrane conductance regulator (CFTR) (Wei et al., 2001) . Stimulation of the cells with forskolin and 3-isobutyl-1-methylxanthine produced activation of CFTR and simultaneously inhibited ATP-dependent activation of endogenous CaCC activity. This effect of CFTR on the regulation of CaCC function was independent of the PDZ domain located at the C terminus of CFTR, but was shown to involve sequences within the R domain. CFTR has also been shown to modulate the function of amiloride-sensitive Na ϩ channels expressed in X. laevis oocytes (Boucherot et al., 2001) . In this study, the first functional nucleotide-binding domain (NBF1) was proposed to be an interaction site between the two channels because mutations in the NBF1 region of CFTR resulted in a decrease in its ability to inhibit amiloride-sensitive Na ϩ channel activity. In this study, we examined the effects of native P2Y receptor subtypes on channel function and observed that several members of the P2Y receptor family modified the functional properties of the channel. To address the hypothesis that these receptors modulate the gating and voltage dependence of the T in channel through membrane-delimited interactions involving specific structural domains of the receptor, we constructed truncation mutants and chimeric receptors involving the C-terminal regions of hP2Y 1 and hP2Y 2 receptors and determined the effects of these mutations on the biophysical properties of the T in channel. Our results indicate that the C-terminal domains of these P2Y receptors are involved in regulating voltage dependence or inactivation gating of the T in channel. An analysis of C-terminal sequences of P2Y receptors suggests that there are protein-protein interaction domains, distinct from their PDZ-binding motifs, which are involved in the coupling and modulation of channel function.
Materials and Methods
Materials. X. laevis frogs were purchased from Xenopus I (Ann Arbor, MI) and maintained in aquaria as suggested by the supplier. Collagenase and gentamicin were obtained from Invitrogen (Carlsbad, CA). 2MeS-ADP and 2MeS-ATP were obtained from Sigma/RBI (Natick, MA Construction of Truncated and Chimeric Receptors. Truncated P2Y receptors were constructed by polymerase chain reaction using a 3Ј primer with a stop codon at the desired location and an XhoI restriction site to aid in subcloning. Chimeric receptors were generated by overlap-extension polymerase chain reaction (Ho et al., 1989) . All receptor constructs were verified by sequencing and were subcloned into pcDNA3.
Preparation of RNA for Injection. cRNA was synthesized from linear cDNA encoding either wild-type P2Y receptor or mutants using Megascript (Ambion, Austin, TX).
Oocyte Isolation and Injection. Ovarian lobes from adult X. laevis frogs were removed from anesthetized animals under sterile condition. The tissue mass was dissociated with collagenase solution (90 mM NaCl, 1 mM KCl, 0.82 mM MgSO 4 , 10 mM HEPES, pH 7.4, and 250 units/ml collagenase). Stage V and VI oocytes were sorted, defolliculated, and maintained in modified Barth's saline solution (MBS solution: 90 mM NaCl, 2 mM KCl, 0.82 mM MgSO 4 , 0.74 mM CaCl 2 , and 10 mM HEPES, pH 7.4, supplemented with 0.05 g/l gentamicin) at 19 to 20°C. Oocytes were injected with cRNA transcripts (46 ng/oocyte) using a Nanoject oocyte injection system (Drummond Scientific (Broomall, PA). Control oocytes were injected with 46 nl of sterile water. Oocytes were stored for 2 to 7 days in MBS solution before analysis.
Peptide Synthesis and Purification. Peptides of 20 amino acids corresponding to the C-terminal sequence of the hP2Y 1 receptor (RKASRRSEANLQSKSEDMTL) or the hP2Y 2 receptor (RRS-DRTDMQRIGDVLGSSED) were synthesized by the MicroChemical Facility at the University of Minnesota (St. Paul, MN). Peptides were purified by high-pressure liquid chromatography before injection, and the appropriate amino acid composition was confirmed by amino acid analysis.
Electrophysiological Measurements. Electrophysiological measurements were made using the two-electrode voltage-clamp technique at 20°C. Recordings were conducted in Cl Ϫ -free MBS solution (90 mM NaMeSO 4 , 2 mM KMeSO 4 , 0.82 mM MgSO 4 , 0.74 mM calcium gluconate, and 10 mM HEPES, pH 7.4). Electrodes were placed in a separate Cl Ϫ -containing MBS solution and connected to the oocyte bathing solution with an agar bridge. Current-and voltage-measuring electrodes were pulled from borosilicate filament glass to resistances between 2 and 5 M⍀ when filled with 0.5 M KCl. Data acquisition and analysis was performed with a Pentium PC using pCLAMP 8 software (Axon Instruments, Inc., Union City, CA).
Analysis and Statistics. Statistical significance was determined using Student's t test. Statistical significance was accepted at p Ͻ 0.05. Conductance-voltage relationships were analyzed using a Boltzmann function (Y ϭ 1/1 ϩ exp(V 50 Ϫ X/slope factor), where V 50 represents the voltage at which the conductance is half-maximal, slope factor represents the relative degree of voltage dependence (steepness of the curve), Y represents the normalized conductance, G/G Ϫ140 mV , and X represents a specific voltage.
Results and Discussion
We previously reported that 2MeS-ADP stimulation of X. laevis oocytes expressing the hP2Y 1 receptor activated a voltage-dependent current with gating characteristics that were identical with the endogenous T in channel in oocytes (O'Grady et al., 1996) . The ability to measure these currents was dependent on receptor expression and on the presence of agonist. We followed up on these initial studies and report here that although all G q -coupled P2Y receptors are capable of activating T in channel currents in the presence of their cognate agonists, the electrophysiological properties of the channel vary markedly depending on the subtype of the receptor.
Bradykinin Activation of the hB 1 -Bradykinin Receptor Elicits T in Currents in X. laevis Oocytes. Figure 1A shows representative T in current traces recorded from ooIon Channel Regulation by P2Y Receptors Fig. 1 . Voltage dependence of the T in current elicited by agonist-activated G q -coupled receptors expressed in X. laevis oocytes. A, representative current traces recorded from oocytes expressing the hB 1 -bradykinin receptor. Oocytes were held at 0 mV and then stepped from Ϫ140 mV to ϩ80 mV in 20-mV increments. The data represent peak inward current at each voltage step. The I-V relationship was fit with a Boltzmann function. The reversal potential of hB 1 -bradykinin receptor was determined from the fit and had a value of ϩ13 mV. B, normalized conductance as a function of voltage for the T in channel activated by hP2Y 1 (n ϭ 13), hP2Y 4 (n ϭ 9), rM 1 -muscarinic (n ϭ 16), and hB 1 -bradykinin (n ϭ 13) receptors. C, normalized conductance as a function of voltage for hB 1 -bradykinin (n ϭ 13), hP2Y 1 (n ϭ 13), hP2Y 11 (n ϭ 15), and the sP2Y (n ϭ 12) receptors. The V 50 values and slope factors for each conductance are listed in Table 1 . D, the effects of hP2Y 1 receptor expression levels on the conductance-voltage relationship of the T in channel; inset: conductance values obtained from oocytes injected with increasing amounts of hP2Y 1 receptor mRNA (nanograms). cytes expressing the G q -coupled hB 1 -bradykinin receptor. Oocytes were held at 0 mV and then stepped to Ϫ140 mV and ϩ80 mV in the presence of a 2 M bradykinin. In the absence of either receptor mRNA or bradykinin, no time-dependent currents were observed upon hyperpolarization. In contrast, bradykinin elicited a characteristic T in channel current in oocytes injected with hB 1 -bradykinin receptor mRNA but not in noninjected oocytes (data not shown). Results for several G q -coupled P2Y receptors were very similar, with the exception that a varying amount of T in channel activation was observed under basal conditions in oocytes expressing P2Y receptors before agonist stimulation (O'Grady et al., 1996) . This basal activation was probably caused by the accumulation in the bathing solution of nucleotides released from oocytes, a result similar to that observed in mammalian cells (Parr et al., 1994; Schachter et al., 1996) .
Voltage Dependence of the T in Current Elicited by Agonist-Activated G q -Coupled Receptors Expressed in X. laevis Oocytes. Figure 1B shows the normalized conductance-voltage relationships for G q -coupled receptors expressed in X. laevis oocytes. Only G q -coupled receptors elicited T in channel currents, because agonist-activated
, and P2Y 12 (20 M 2MeS-ADP; G i -coupled) receptors were unable to activate T in currents after hyperpolarization (data not shown). The conductancevoltage curves were analyzed using a Boltzmann function, where V 50 represents the voltage at which the conductance was half-maximal (described under Materials and Methods). The V 50 value for the conductance activated by the hP2Y 1 receptor, but not the rat (r) M 1 -muscarinic or hP2Y 4 receptor, was shifted markedly to a more negative voltage compared with the conductance activated by the hB 1 -bradykinin receptor and was significantly different from the V 50 value elicited by the hB 1 -bradykinin receptor (Table 1) . Two other P2Y receptors, the hP2Y 11 and the sP2Y receptors, also activated currents with significantly more negative V 50 values than the currents activated by the hB 1 -bradykinin or the rM 1 -muscarinic receptor (Fig. 1C) (Table 1) .
To investigate the effect of receptor expression levels on the voltage sensitivity of the T in channel, we injected increasing amounts of hP2Y 1 receptor mRNA into oocytes and monitored the conductance-voltage relationships after receptor activation with a maximum activating concentration (20 M) of 2MeS-ADP (O'Grady et al., 1996) (Fig. 1D) . Whereas increasing hP2Y 1 receptor mRNA elicited higher peak conductance levels, it had no effect on the voltage sensitivity of the T in channel. These data strongly suggest that the modulation of T in channel voltage sensitivity by the hP2Y 1 receptor is independent of the level of receptor expression.
Role of the hP2Y 1 Receptor C Terminus in Modulating T in Channel Voltage Sensitivity. The data presented above suggest that the hP2Y 1 and hP2Y 11 receptors not only activate T in channels, but also modulate channel properties, possibly through direct protein-protein interactions. To test this hypothesis, we examined the conductance-voltage relationship of the T in current elicited by a chimeric hB 1 -bradykinin receptor in which the C-terminal domain was replaced by the C-terminal region from the hP2Y 1 receptor (hB 1 /Y 1 ). Figure 2A shows that the conductance-voltage relationship of the T in channel elicited by the hB 1 /Y 1 chimeric receptor was essentially identical with that elicited by the activated hP2Y 1 receptor. These data demonstrate a "gain in function" of the hB 1 -bradykinin receptor containing the hP2Y 1 receptor Cterminal domain and strongly suggest that the C-terminal region of the hP2Y 1 receptor is involved in regulating the properties of the T in channel.
To further characterize the region of the hP2Y 1 receptor C-terminal domain involved in modulating the biophysical properties of the T in channel, we analyzed the conductancevoltage relationships of the T in current elicited by a series of carboxyl terminal truncations (Fig. 2B) . Removal of either the PDZ-binding motif (hP2Y 1 369tr) or the last 13 amino acids (hP2Y 1 360tr) from the C terminus of the hP2Y 1 receptor had no effect on the V 50 values for the T in channel compared with the full-length wild-type receptor (Fig. 2C) (Table  1) . In contrast, deletion of either 31 (hP2Y 1 342tr) or 39 (hP2Y 1 334tr) amino acids from the C terminus resulted in V 50 values that were very similar to those elicited by hB 1 -bradykinin, rM 1 -muscarinic, and hP2Y 4 receptors (Fig. 2D) ( Table 1) . Deletion of 24 amino acids (hP2Y 1 349tr) resulted in an intermediate phenotype, with a V 50 value in between the full-length hP2Y 1 receptor and the truncation mutant missing the entire C-terminal domain.
Role of the C-Terminal Domain of the hP2Y 2 and rP2Y 6 Receptors in T in Channel Inactivation Gating. We also observed a marked difference in the inactivation gating of the T in channel depending on which P2Y receptor was responsible for activating the current. Thus, whereas the current elicited by the hP2Y 1 receptor was almost completely inactivated within 3 s of the hyperpolarizing pulse, the current elicited by either the hP2Y 2 (stimulated with 40 M UTP) or the rP2Y 6 receptor (stimulated with 40 M UDP) showed significantly slower inactivation. (Fig. 3A) . As observed with the voltage gating of the channel, the time course of inactivation was dependent on the identity of the C-terminal domain of the receptor. Thus, the inactivation time Fig. 2 . Effect of C-terminal truncation on the conductance-voltage relationship. A, normalized conductance as a function of voltage for T in currents elicited by activated hB 1 -bradykinin (n ϭ 13), hP2Y 1 (n ϭ 13), and hB 1 /Y 1 chimeric (n ϭ 6) receptors. B, location of truncation mutations introduced into the hP2Y 1 receptor. The last four amino acids, DTSL, represent a consensus class 1 PDZ-binding motif. C, normalized conductance as a function of voltage for T in currents elicited by activated hB 1 -bradykinin (n ϭ 13), hP2Y 1 (n ϭ 13), hP2Y 1 360tr (n ϭ 17), and hP2Y 1 369tr (n ϭ 10) receptors. D, normalized conductance as a function of voltage for T in currents elicited by activated hP2Y 1 (n ϭ 13), hP2Y 1 334tr (n ϭ 9), hP2Y 1 342tr (n ϭ 18), and hP2Y 1 349tr (n ϭ 9) receptors. The V 50 values and slope factors for each conductance are listed in Table 1 . courses of the hP2Y 1 receptor containing the hP2Y 2 C-terminal domain (hY 1 /Y 2 chimera) (Fig. 3A) or the hB 1 -bradykinin receptor containing the hP2Y 2 C-terminal domain (hB 1 /Y 2 ) (Fig. 3B) were identical with that of the wild-type hP2Y 2 receptor (Fig. 3A) . Figure 3C shows the ratio of the current amplitude at the end of the voltage pulse (Ϫ140 mV, 3.8 s) to the maximum inward current elicited by a series of activated receptors. As suggested by the current traces in Fig. 3, A and B , the ratio derived from the hP2Y 1 receptor-activated currents was near zero. In contrast, the ratio was nearly 0.8 for the current elicited by the hP2Y 2 receptor, rP2Y 6 receptor, and the hY 1 /Y 2 chimera, indicating slow inactivation. Although the ratio of the current elicited by the hY 2 /Y 1 chimera was significantly decreased compared with wild-type hP2Y 2 receptor, it was still significantly greater than that observed after hP2Y 1 and hP2Y 4 receptor activation.
C-Terminal Sequence Comparisons of P2Y Receptors. Figure 4 compares the C-terminal sequences of all five of the G q -coupled P2Y receptors (P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , and P2Y 11 ). Within the C-terminal domains of the hP2Y 1 , hP2Y 11 , and sP2Y receptor, all of which modulate the voltage activation of the T in channel, a common sequence motif was observed (RRSE-QXK/RSE) (bold letters identify conserved amino acids between P 2 Y receptor subtypes). Importantly, this sequence motif falls within the narrow region of the hP2Y 1 receptor C-terminal domain shown to be involved in modulating voltage sensitivity (Fig. 2) . Likewise, a different conserved sequence motif (QRXG/R) was observed in the C-terminal domains of the hP2Y 2 and rP2Y 6 receptor, both of which modulate T in channel inactivation. This motif is not present in the other P2Y receptors.
Effects of Y1 and Y2 C-Terminal Peptides on the Conductance-Voltage Relationships and Inactivation
Gating of the T in Channel. To examine whether the unique sequence motif present in the C-terminal region of the hP2Y 1 receptor was able to modulate the conductance-voltage relationship of the T in current, a synthetic peptide (Y1 peptide) (boxed region in Fig. 4 ) was injected into hP2Y 1 342tr-expressing oocytes (final concentration Ϸ 500 nM), and the conductance-voltage relationship of the T in channel was determined (Fig. 5A) . The V 50 value of the conductance elicited by the hP2Y 1 342tr receptor with 500 nM Y1 peptide (Ϫ72.3 mV) was significantly different from the value elicited by the hP2Y 1 342tr receptor alone (V 50 ϭ Ϫ49.0 mV) and similar to that elicited by the wild-type hP2Y 1 receptor (V 50 ϭ Ϫ72.5 mV) ( Table 1 ). The Y1 peptide produced a similar negative shift in the V 50 value (Ϫ68.0 mV) in oocytes expressing the hB 1 -bradykinin receptor compared with the hB 1 -bradykinin receptor alone (Ϫ43.0 mV) (Fig. 5B) .
To examine whether the proposed sequence motif present in the C-terminal region of the hP2Y 2 receptor was able to modulate the inactivation gating of the T in current, a 20 amino acid peptide (Y2 peptide) (boxed region in Fig. 4 ) from the C terminus of the hP2Y 2 receptor encompassing this Fig. 3 . Inactivation gating of receptor-activated T in currents. A, representative traces of the T in conductance elicited by activated hP2Y 1 , rP2Y 6 , hP2Y 2 , and hY 1 /Y 2 chimeric receptors. T in channels were monitored for 5 s in the presence of the appropriate receptor agonist. UTP (40 M) and UDP (40 M) were used to stimulate the hP2Y 2 and rP2Y 6 receptors, respectively (Parr et al., 1994; . 2MeS-ADP (20 M) was used to activate the hP2Y 1 receptor and hY 1 /Y 2 chimeric receptors. B, representative traces of currents elicited by agonistactivated hB 1 -bradykinin and hB 1 /Y 1 , and hB 1 /Y 2 chimeric receptors after step hyperpolarization to Ϫ140 mV. C, I final /I max is the current amplitude at the end of the voltage pulse (as indicated by the open arrows in parts A and B) divided by the maximum inward current and represents the degree of T in channel inactivation gating. This ratio was significantly increased in hP2Y 2 (n ϭ 10), rP2Y 6 (n ϭ 11), hY 1 /Y 2 (n ϭ 7), hY 2 /Y 1 (n ϭ 7) , and hB 1 /Y 2 (n ϭ 7) chimeric receptors (p Ͻ 0.05). sequence was injected into hP2Y 1 342tr-or hB 1 -bradykinin receptor-injected oocytes (final concentration Ϸ 500 nM), and the inactivation gating of the T in channel was determined. Figure 5C shows the ratio of the current amplitude at the end of the voltage pulse (Ϫ140 mV) to the maximum inward current observed after activation. The ratio obtained from the hP2Y 1 342tr and hB 1 -bradykinin receptor-activated currents was nearly zero, whereas the ratio for the current elicited by hP2Y 1 342tr or hB 1 -bradykinin receptor with Y2 peptide was significantly increased (although not to the same level) compared with hP2Y 1 342tr and hB 1 -bradykinin receptor-activated currents alone or hP2Y 1 342tr and hB 1 -bradykin receptor-activated currents with Y1 peptide.
Taken together, these data strongly suggest that the C termini of the hP2Y 1 and hP2Y 2 receptors interact in some manner with the T in channel to modulate its biophysical properties. We hypothesize that two sequence motifs, RRSE-QXK/RSE and QRXG/R, located in the C-termini of P2Y receptors, are important protein-protein interaction sites between P2Y receptors and the T in channel, or alternatively an intermediate adapter protein. The presence of multiple protein-protein interaction domains within the C-terminal region of P2Y receptors suggests that these receptors can couple to a variety of membrane-associated proteins and potentially influence their function, independent of G-protein activation. Future studies directed toward identifying additional interacting protein partners should provide better insight into the role of protein-protein interactions in P2Y receptor signaling. 5 . Effect of Y1 and Y2 C-terminal peptides on the conductancevoltage relationship and inactivation gating of T in currents. A, normalized conductance as a function of voltage of T in currents elicited by the agonist-activated hP2Y 1 342tr receptor (Y 1 tr; n ϭ 18), hP2Y 1 342tr receptor with 500 nM Y1 peptide (n ϭ 8), and hP2Y 1 receptor (n ϭ 13). B, normalized conductance as a function of voltage of T in currents elicited by the hB 1 -bradykinin receptor (n ϭ 13), the hB 1 -bradykinin receptor with 500 nM Y1 peptide (n ϭ 7), and the hP2Y 1 receptor (n ϭ 13). C, I final /I max ratios of the T in current elicited by the indicated receptors were calculated as described in the legend to Fig. 3 . The ratios were significantly increased for the hP2Y 1 342tr receptor with 500 nM Y2 peptide (n ϭ 6), the hB 1 -bradykinin receptor with 500 nM Y2 peptide (n ϭ 6), and the hP2Y 2 receptor (n ϭ 10) (p Ͻ 0.05). 
